Sherriff---The announcement made by the company was extremely...

Sherriff---The announcement made by the company was extremely positive,I vividally remember Dr. Bill Garner (Founder of Inversion) commenting at the 2012 agm that if Nadalol treated cystic fibrosis-in his words --it was game over-(basically name your price!) Nadalol has the capacity to to heal the lungs, no other drug has this ability.
Hence Invion wanting to take this drug to commercialisation.(Cystic fibrosis at the moment is only treated as a last resort by a lung transplant and most sufferers do not live past the age of 30 without a transplant))
So it appears that Invion have a two pronged attack-develop Nadalol with 3M,- and partner inv 103 with a major Pharma.Then sell inv102 to the highest bidder.(Several Billion)
Also inv 103( cpn10,also known as hsp 10 and epf. ) has the capacity as a ramp to reverse the symptoms of autoimmune diseases ,there are up to 80 autoimmune diseases including altizermers and aids which have been identified by CBio.(Several Billion)
All this for 9cents-you have to be joking.(those selling at these amounts are in either dire straits or not interested in extreme capital gains)This is not a pipe dream.
As you are aware that institutional investors are clamouring for this stock and have had to have their allocations severely cut back.Institutional investors normally do not buy stock if a company is not valued at minimum $100 million let alone one valued in the low 40's.
Say no more!